Reinier Beeuwkes

Founder at Braintree Laboratories, Inc.

Health Technology

Profile

Reinier Beeuwkes is the founder of Braintree Laboratories, Inc., which was founded in 1982.
He holds the title of Director at Braintree Laboratories, Inc. Dr. Beeuwkes's current job is Director at Ischemix, Inc., where he started in 2002.
Dr. Beeuwkes's former job was Chairman & Chief Executive Officer at Citius Pharmaceuticals, Inc.

Reinier Beeuwkes active positions

Companies	Position	Start
Braintree Laboratories, Inc. Braintree Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Braintree Laboratories, Inc. manufactures pharmaceutical products and drugs. Its products include SUPREP, NuLYTELY and GoLYTELY. The company was founded by Harry Keegan III and Reinier Beeuwkes in 1982 and is headquartered in Braintree, MA.	Founder	31/12/1981
Ischemix, Inc. Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013.	Director/Board Member	31/12/2001

All active positions of Reinier Beeuwkes

Former positions of Reinier Beeuwkes

Companies	Position	End
CITIUS PHARMACEUTICALS, INC.	Chief Executive Officer	11/09/2014

See the detail of Reinier Beeuwkes's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Reinier Beeuwkes's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
CITIUS PHARMACEUTICALS, INC.	Health Technology

Private companies	2
Braintree Laboratories, Inc. Braintree Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Braintree Laboratories, Inc. manufactures pharmaceutical products and drugs. Its products include SUPREP, NuLYTELY and GoLYTELY. The company was founded by Harry Keegan III and Reinier Beeuwkes in 1982 and is headquartered in Braintree, MA.	Health Technology
Ischemix, Inc. Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013.	Health Technology